Lawrence J. Jasinski - Mar 28, 2024 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Role
Director
Signature
/s/ David C. Hissong
Stock symbol
LMAT
Transactions as of
Mar 28, 2024
Transactions value $
$0
Form type
4
Date filed
4/1/2024, 05:28 PM
Previous filing
Mar 7, 2024
Next filing
May 23, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LMAT Dividend Equivalent Rights Award $0 +0.476 +7.39% $0.00 6.91 Mar 28, 2024 Common Stock 0.476 Direct F1
transaction LMAT Dividend Equivalent Rights Award $0 +0.964 +19.33% $0.00 5.95 Mar 28, 2024 Common Stock 0.964 Direct F2
transaction LMAT Dividend Equivalent Rights Award $0 +0.964 +24.11% $0.00 4.96 Mar 28, 2024 Common Stock 0.964 Direct F3
transaction LMAT Dividend Equivalent Rights Award $0 +1.23 $0.00 1.23 Mar 28, 2024 Common Stock 1.23 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F2 These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F3 These dividend equivalent rights accrued on a Performance Stock Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F4 These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.